Rocuronium bromide

罗库溴铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRocuronium bromide
Drug Alias Name罗库澳铵罗库溴胺EsmeronEslaxMyocron +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsMuscle relaxation agents
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsHypothermiaHeart ArrestHyperemesis Gravidarum +[6] 
Global Approved IndicationsHyperemesis GravidarumAnesthesia
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryUnited States
Original Approved Date1994/03/17
Country/TerritoryUnited StatesAustriaEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrganon
China Registration ClassN/A

Develop Information

Active CompaniesN.V. Organon
Inactive CompaniesHameln Pharmaceuticals GmbhOrganon Usa IncMedical University Of Vienna +[7] 
Active IndicationsHyperemesis Gravidarum
Inactive IndicationsHypothermiaHeart ArrestSpinal Dysraphism +[5] 

Other Information

ATC CodeM03AC09
Related LinksWikipediaDrugBankKEGG